Combining routine morphology, p16INK4a immunohistochemistry, and in situ hybridization for the detection of human papillomavirus infection in penile carcinomas: A tissue microarray study using classifier performance analyses

Backes, 2009, Systematic review of human papillomavirus prevalence in invasive penile cancer, Cancer Causes Control, 20, 449, 10.1007/s10552-008-9276-9 Miralles-Guri, 2009, Human papillomavirus prevalence and type distribution in penile carcinoma, J Clin Pathol, 62, 870, 10.1136/jcp.2008.063149 Cubilla, 2011, Value of p16INKα in the pathology of invasive penile squamous cell carcinomas: A report of 202 cases, Am J Surg Pathol, 35, 253, 10.1097/PAS.0b013e318203cdba Cubilla, 2010, The basaloid cell is the best tissue marker for human papillomavirus in invasive penile squamous cell carcinoma: A study of 202 cases from Paraguay, Am J Surg Pathol, 34, 104, 10.1097/PAS.0b013e3181c76a49 Rubin, 2001, Detection and typing of human papillomavirus DNA in penile carcinoma: Evidence for multiple independent pathways of penile carcinogenesis, Am J Pathol, 159, 1211, 10.1016/S0002-9440(10)62506-0 Gregoire, 1995, Preferential association of human papillomavirus with high-grade histologic variants of penile-invasive squamous cell carcinoma, J Natl Cancer Inst, 87, 1705, 10.1093/jnci/87.22.1705 Epstein, 2011, Tumors of the Prostate Gland, seminal vesicles, penis, and scrotum. Atlas of Tumor Pathology, 405 Castellsagué, 2002, Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners, N Engl J Med, 346, 1105, 10.1056/NEJMoa011688 Castellsagué, 2003, The male role in cervical cancer, Salud Publica Mex, 45, S345, 10.1590/S0036-36342003000900008 Shariat, 2007, Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressiveness, Mod Pathol, 20, 445, 10.1038/modpathol.3800757 Shariat, 2004, p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer, J Clin Oncol, 22, 1014, 10.1200/JCO.2004.03.118 Yavuzer, 2011, Role of human papillomavirus in the development of urothelial carcinoma, Med Oncol, 28, 919, 10.1007/s12032-010-9540-1 Ben Selma, 2010, Investigation of human papillomavirus in bladder cancer in a series of Tunisian patients, Pathol Res Pract, 206, 740, 10.1016/j.prp.2010.06.005 Cai, 2011, Human papillomavirus and non-muscle invasive urothelial bladder cancer: Potential relationship from a pilot study, Oncol Rep, 25, 485, 10.3892/or.2010.1083 Higgins, 2007, Placental S100 (S100P) and GATA3: Markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray, Am J Surg Pathol, 31, 673, 10.1097/01.pas.0000213438.01278.5f Kaufmann, 2000, Uroplakin III is a highly specific and moderately sensitive immunohistochemical marker for primary and metastatic urothelial carcinomas, Am J Clin Pathol, 113, 683, 10.1309/PYQC-17CB-063T-Q07J Parker, 2003, Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas, Am J Surg Pathol, 27, 1, 10.1097/00000478-200301000-00001